Literature DB >> 23933488

15-Lipoxygenases in cancer: a double-edged sword?

Adi J Klil-Drori1, Amiram Ariel.   

Abstract

Among the lipoxygenases, a diverse family of fatty acid dioxygenases with varying tissue-specific expression, 15-lipoxygenase (15-LOX) was found to be involved in many aspects of human cancer, such as angiogenesis, chronic inflammation, metastasis formation, and direct and indirect tumor suppression. Herein, evidence for the expression and action of 15-LOX and its orthologs in various neoplasms, including solid tumors and hematologic malignancies, is reviewed. The debate surrounding the impact of 15-LOX as either a tumor-promoting or a tumor-suppressing enzyme is highlighted and discussed in the context of its role in other biological systems.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arachidonic acid; Docosahexaenoic acid; Lipoxygenase; Neoplastic growth; Tumor biology

Mesh:

Substances:

Year:  2013        PMID: 23933488     DOI: 10.1016/j.prostaglandins.2013.07.006

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  13 in total

1.  Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways.

Authors:  Nella Prevete; Federica Liotti; Anna Illiano; Angela Amoresano; Piero Pucci; Amato de Paulis; Rosa Marina Melillo
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

2.  Human 15-LOX-1 active site mutations alter inhibitor binding and decrease potency.

Authors:  Michelle Armstrong; Christopher van Hoorebeke; Thomas Horn; Joshua Deschamps; J Cody Freedman; Chakrapani Kalyanaraman; Matthew P Jacobson; Theodore Holman
Journal:  Bioorg Med Chem       Date:  2016-08-31       Impact factor: 3.641

3.  15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.

Authors:  Fei Mao; Min Xu; Xiangsheng Zuo; Jiang Yu; Weiguo Xu; Micheline J Moussalli; Elias Elias; Haiyan S Li; Stephanie S Watowich; Imad Shureiqi
Journal:  FASEB J       Date:  2015-02-24       Impact factor: 5.191

Review 4.  Male infertility and somatic health - insights into lipid damage as a mechanistic link.

Authors:  Nathan D Burke; Brett Nixon; Shaun D Roman; John E Schjenken; Jessica L H Walters; R John Aitken; Elizabeth G Bromfield
Journal:  Nat Rev Urol       Date:  2022-09-13       Impact factor: 16.430

5.  A high throughput screen identifies potent and selective inhibitors to human epithelial 15-lipoxygenase-2.

Authors:  J Brian Jameson; Auric Kantz; Lena Schultz; Chakrapani Kalyanaraman; Matthew P Jacobson; David J Maloney; Ajit Jadhav; Anton Simeonov; Theodore R Holman
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

Review 6.  Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.

Authors:  Gillian Y Moore; Graham P Pidgeon
Journal:  Int J Mol Sci       Date:  2017-01-24       Impact factor: 5.923

7.  Computational Analysis of LOX1 Inhibition Identifies Descriptors Responsible for Binding Selectivity.

Authors:  Chrysoula Gousiadou; Irene Kouskoumvekaki
Journal:  ACS Omega       Date:  2018-02-26

Review 8.  Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal.

Authors:  Antonio Ayala; Mario F Muñoz; Sandro Argüelles
Journal:  Oxid Med Cell Longev       Date:  2014-05-08       Impact factor: 6.543

9.  Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.

Authors:  Akram Mohammed; Greyson Biegert; Jiri Adamec; Tomáš Helikar
Journal:  Oncotarget       Date:  2017-09-21

Review 10.  Redox regulation of tumor suppressor PTEN in cell signaling.

Authors:  Ying Zhang; Jiyoung Park; Seong-Jeong Han; Sung Yeul Yang; Hyun Joong Yoon; Iha Park; Hyun Ae Woo; Seung-Rock Lee
Journal:  Redox Biol       Date:  2020-05-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.